Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The association of genetic polymorphisms in protocadherin 15 with sudden sensorineural hearing loss in a Chinese population. | J Clin Lab Anal | 2023 | 37198144 | PubTator, text mining | PubMed |
| T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications. | PLoS One | 2023 | 37192179 | PubTator, text mining | PubMed |
| Familial Whole Exome Sequencing Study of 30 Families With Early-Onset High Myopia. | Invest Ophthalmol Vis Sci | 2023 | 37191617 | PubTator, text mining | PubMed |
| Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma. | Sci Rep | 2023 | 37185612 | PubTator, text mining | PubMed |
| Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer. | Front Oncol | 2023 | 37182133 | PubTator, text mining | PubMed |
| Identification of m6A-related lncRNAs as prognostic signature within colon tumor immune microenvironment. | Cancer Rep (Hoboken) | 2023 | 37178411 | PubTator, text mining | PubMed |
| A nonsense mutation in C8orf37 linked with retinitis pigmentosa, early macular degeneration, cataract, and myopia in an arRP family from North India. | BMC Ophthalmol | 2023 | 37170250 | PubTator, text mining | PubMed |
| Subtypes analysis and prognostic model construction based on lysosome-related genes in colon adenocarcinoma. | Front Genet | 2023 | 37168510 | PubTator, text mining | PubMed |
| Mitoribosome Biogenesis. | Methods Mol Biol | 2023 | 37166630 | PubTator, text mining | PubMed |
| Unravelling the genetic basis of retinal dystrophies in Pakistani consanguineous families. | BMC Ophthalmol | 2023 | 37165311 | PubTator, text mining | PubMed |
| Artificial intelligence in retinal disease: clinical application, challenges, and future directions. | Graefes Arch Clin Exp Ophthalmol | 2023 | 37160501 | PubTator, text mining | PubMed |
| Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37155150 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals a molecular landscape of the early recurrence and early metastasis in pan-cancer. | Front Genet | 2023 | 37152984 | PubTator, text mining | PubMed |
| Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma. | PLoS One | 2023 | 37146093 | PubTator, text mining | PubMed |
| The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma. | Front Pharmacol | 2023 | 37138850 | PubTator, text mining | PubMed |
| Genomic Analysis of Human Brain Metastases Treated with Stereotactic Radiosurgery Under the Phase-II Clinical Trial (NCT03398694) Reveals DNA Damage Repair at the Peripheral Tumor Edge. | medRxiv | 2023 | 37131583 | PubTator, text mining | PubMed |
| The genetic landscape of inherited retinal dystrophies in Arabs. | BMC Med Genomics | 2023 | 37127645 | PubTator, text mining | PubMed |
| Generation of the induced pluripotent stem cell line SFMUi001-A from a patient with usher syndrome type 2 caused by biallelic variants in the USH2A gene. | Stem Cell Res | 2023 | 37126974 | PubTator, text mining | PubMed |
| The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications. | Front Cell Dev Biol | 2023 | 37123408 | PubTator, text mining | PubMed |
| A Review of CRISPR Tools for Treating Usher Syndrome: Applicability, Safety, Efficiency, and In Vivo Delivery. | Int J Mol Sci | 2023 | 37108761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=19